CRVO
CervoMed Inc.
3.00$
+3.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | +63.2% | -5.8% | +40.1% | -41.0% | +11.4% | -11.3% | -8.3% | -81.6% | -97.3% | -100.0% | – | – | |
| – | +0.0% | – | – | – | +3.1% | -0.7% | – | – | +8.2% | – | – | – | – | – | – | – | – | – | – | – | +36.7% | +1,310.8% | – | – | +15.2% | +381.5% | – | – | +59.4% | -1.4% | +185.9% | -36.3% | +38.3% | -31.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -196.8% | – | – | – | – | – | – | – | – | |
| – | -24.6% | -31.1% | +17.1% | +49.1% | -35.1% | +59.9% | -23.8% | -15.9% | +16.7% | +24.5% | -10.7% | +14.9% | -4.9% | -7.4% | +41.6% | +44.4% | -17.7% | +12.9% | -32.4% | +6.7% | -28.6% | +61.2% | -13.1% | -84.3% | +476.2% | -3.7% | +6.8% | -8.5% | +59.4% | -1.4% | +34.0% | +35.9% | +38.3% | -31.7% | +5.6% | +18.2% | -3.5% | -11.9% | -15.8% | – | |
| – | -73.4% | +51.8% | +15.6% | -13.2% | -17.7% | +16.8% | +10.9% | -4.3% | -10.7% | -15.4% | -11.1% | +20.8% | -1.2% | +9.3% | +4.6% | +44.9% | -30.0% | +17.8% | +5.3% | +5.1% | +0.3% | +10.0% | +0.4% | -73.2% | +308.8% | -57.3% | -0.8% | +142.8% | -12.2% | +0.6% | +18.0% | -12.0% | +4.8% | +2.9% | +37.1% | -28.8% | +7.9% | +18.5% | -20.8% | – | |
| – | -689.7% | – | +16.1% | -212.2% | – | – | – | +126.5% | +364.1% | -91.0% | -189.8% | – | -3.0% | -0.1% | +23.8% | +44.2% | -22.5% | +14.6% | -18.2% | +231.2% | -72.7% | +31.4% | -6.8% | -78.7% | +370.0% | -66.4% | -13.7% | +117.3% | -7.3% | +4.6% | +15.4% | +80.2% | +34.2% | -26.8% | +24.8% | +26.5% | -0.4% | -2.7% | -17.7% | – | |
| – | – | -107.5% | – | – | +505.0% | -83.4% | -191.9% | – | – | – | – | -216.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,992.3% | +10,048.4% | -99.4% | -93.0% | – | – | +21.0% | -16.2% | -18.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -75.0% | -85.6% | -551.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -209.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -433.1% | – | – | – | -144.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | -50.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -75.0% | -64.9% | -285.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -209.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -150.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +47.0% | -179.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.